MARKETS / NASDAQ / STEX
NASDAQ · ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS · SMALL CAP

Streamex Corp. STEX

13 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
EPS · FY25
$-9.65
Dividend / sh · FY25
Payout · FY25
ROE · FY25
-703.1%
Net margin · FY25
Dividend coverage
Advertisement
AdSense · Leaderboard 728×90320×100
Result
Revenue, FY2025 · full 13-year series below
Revenue Net income
0.00020.00040.0006-0.520132016201920222025
0.00020.00040.0006-0.52016201920222025

Per share
USD -9.65
Diluted EPS, FY2025
EPS
0.40.81.2-9.6520132016201920222025
0.40.81.2-9.652016201920222025

The company pays no cash dividend.

Profitability
-703.1%
Return on equity, FY2025
ROE
0.250.50.751-703.1%20132016201920222025
0.250.50.751-703.1%2016201920222025
Operating margin
Net margin
Return on assets-491.3%

Each USD of equity lost 703 cents this year.

Returned to shareholders
returned in FY2025 · dividends + net buybacks
Dividends paid
Net buybacks
Share of profit
Consecutive raises

Growth
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
−55.1%

Compound annual rates per period — left blank where the series crosses a loss.

Share base
0.05B
Shares outstanding, FY2025
0.010.0520132016201920222025
0.000.052016201920222025
Change, 5 years+57.5%
Change, 10 years

The share count grew 57% in five years — the same company, cut into more, smaller slices.

Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 187.5M
total assets, end of FY2025
Total assetsUSD 187.5M
EquityUSD 133.2M
CashUSD 20.3M
DepositsUSD 19.7M
Current ratio1.68×

Equity funds 71% of total assets.

History
13 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
Revenue $B
·
0.0
0.0
0.0
0.0
0.0
·
·
·
·
·
·
·
Operating income $B
−0.1
−0.0
−0.0
−0.0
−0.0
−0.1
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
EBITDA $B
−0.1
−0.0
−0.0
−0.0
−0.0
−0.1
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
Income tax $B
−0.0
·
·
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Net income $B
−0.5
−0.0
−0.0
−0.0
−0.0
−0.1
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
EPS, diluted $
−9.65
−0.75
−3.95
−6.33
·
−1.87
−1.65
−1.25
−1.25
−0.60
−0.70
−0.91
−1.23
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
·
·
·
·
ROE %
−703.1
·
·
−431.0
−174.4
−294.1
−470.7
−48736.5
·
·
·
·
·
Shares out B
0.05
0.02
0.01
0.05
0.04
0.03
0.02
0.02
0.00
0.00
0.00
0.01
0.01

Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.

How we verifyAUDITED
41 of 41
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity

Every figure was compared against the original statement: 0 failures and 0 presentation gaps.

What we don’t show

We’d rather say what’s missing than fill the gap with an estimate.

P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed